1. African swine fever virus pB475L evades host antiviral innate immunity via targeting STAT2 to inhibit IFN-I signaling.
- Author
-
Huang Z, Mai Z, Kong C, You J, Lin S, Gao C, Zhang W, Chen X, Xie Q, Wang H, Tang S, Zhou P, Gong L, and Zhang G
- Subjects
- Animals, Humans, African Swine Fever immunology, African Swine Fever virology, African Swine Fever metabolism, African Swine Fever genetics, HEK293 Cells, Immune Evasion, STAT1 Transcription Factor metabolism, STAT1 Transcription Factor genetics, Swine, African Swine Fever Virus immunology, African Swine Fever Virus genetics, Immunity, Innate, Interferon Type I metabolism, Interferon Type I immunology, Signal Transduction, STAT2 Transcription Factor metabolism, STAT2 Transcription Factor genetics, Viral Proteins genetics, Viral Proteins metabolism, Viral Proteins immunology
- Abstract
African swine fever virus (ASFV) causes severe disease in domestic pigs and wild boars, seriously threatening the development of the global pig industry. Type I interferon (IFN-I) is an important component of innate immunity, inducing the transcription and expression of antiviral cytokines by activating Janus-activated kinase-signal transducer and activator of transcription (STAT). However, the underlying molecular mechanisms by which ASFV antagonizes IFN-I signaling have not been fully elucidated. Therefore, using coimmunoprecipitation, confocal microscopy, and dual luciferase reporter assay methods, we investigated these mechanisms and identified a novel ASFV immunosuppressive protein, pB475L, which interacts with the C-terminal domain of STAT2. Consequently, pB475L inhibited IFN-I signaling by inhibiting STAT1 and STAT2 heterodimerization and nuclear translocation. Furthermore, we constructed an ASFV-B475L
7PM mutant strain by homologous recombination, finding that ASFV-B475L7PM attenuated the inhibitory effects on IFN-I signaling compared to ASFV-WT. In summary, this study reveals a new mechanism by which ASFV impairs host innate immunity., Competing Interests: Conflict of interest The research was conducted without commercial or financial relationships that could be construed as a potential conflict of interest. The authors declare that they have no conflicts of interest with the contents of this article., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF